tm logo

About 13 Trademarks found that are owned by Viela Bio Inc.

Filters

88420342
Live/Registered

on 24 Nov 2020

VIELABIO

VIELA BIO, INC.

88420342 · 08 May 2019

24 Nov 2026

005

Pharmaceutical products for the treatment of rare autoimmune diseases ...

88420346
Live/Registered

on 24 Nov 2020

VIELABIO

VIELA BIO, INC.

88420346 · 08 May 2019

24 Nov 2026

005

Color is not claimed as a feature of the mark.,Pharmaceutical products...

88045691
Live/Registered

on 29 Sep 2020

UPLIZNA

VIELA BIO, INC.

88045691 · 20 Jul 2018

29 Sep 2026

005

Pharmaceutical products for the treatment of rare autoimmune diseases ...

88149112
Live/Registered

on 05 Mar 2019

VIELABIO

VIELA BIO, INC.

88149112 · 10 Oct 2018

05 Mar 2025

042

Research and development in the field of inflammation and autoimmune d...

88149113
Live/Registered

on 05 Mar 2019

VIELABIO

VIELA BIO, INC.

88149113 · 10 Oct 2018

05 Mar 2025

042

Research and development in the field of inflammation and autoimmune d...

98330251
Live/Pending

on 25 Jul 2024

DAXFYTRA

Viela Bio, Inc.

98330251 · 26 Dec 2023

005

044

Pharmaceutical preparations,Providing information featuring health inf...

98330249
Live/Pending

on 25 Jul 2024

XUBLEANT

Viela Bio, Inc.

98330249 · 26 Dec 2023

005

044

Pharmaceutical preparations,Providing information featuring health inf...

98330250
Live/Pending

on 25 Jul 2024

VAHZENNI

Viela Bio, Inc.

98330250 · 26 Dec 2023

005

044

Pharmaceutical preparations,Providing information featuring health inf...

90081526
Dead/Abandoned

on 10 Apr 2023

UP

VIELA BIO, INC.

90081526 · 29 Jul 2020

005

Pharmaceutical products for the treatment of rare autoimmune diseases ...

88067980
Dead/Abandoned

on 13 Sep 2021

PEVTOZI

VIELA BIO, INC.

88067980 · 07 Aug 2018

005

Pharmaceutical products for the treatment of rare autoimmune diseases ...

Status

All

Registered

Pending

Abandoned

Other

Categories

Class 5 (11)

Class 44 (3)

Class 42 (2)

Attorney

Elsa d lemoine (8)

Susan neuberger weller (4)

Frances m jagla (1)

Correspondents

Elsa d lemoine (5)

Mintz levin cohn ferris glovsky and (4)

Amgen inc. (3)

Frances m jagla (1)

Page 1 of 2